149 related articles for article (PubMed ID: 1468689)
1. Molecular genetic changes in human epithelial ovarian malignancies.
Gallion HH; Powell DE; Morrow JK; Pieretti M; Case E; Turker MS; DePriest PD; Hunter JE; van Nagell JR
Gynecol Oncol; 1992 Nov; 47(2):137-42. PubMed ID: 1468689
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
3. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
4. Human epithelial ovarian cancer allelotype.
Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity and K-ras gene mutations in gastric cancer.
Ranzani GN; Renault B; Pellegata NS; Fattorini P; Magni E; Bacci F; Amadori D
Hum Genet; 1993 Oct; 92(3):244-9. PubMed ID: 8406432
[TBL] [Abstract][Full Text] [Related]
7. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome.
Saretzki G; Hoffmann U; Röhlke P; Psille R; Gaigal T; Keller G; Höfler H; Löning T; Petersen I; Dietel M
Cancer; 1997 Oct; 80(7):1241-9. PubMed ID: 9317174
[TBL] [Abstract][Full Text] [Related]
8. Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.
Kiechle-Schwarz M; Bauknecht T; Wienker T; Walz L; Pfleiderer A
Cancer; 1993 Oct; 72(8):2423-32. PubMed ID: 8402459
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
Ittmann MM
Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
[TBL] [Abstract][Full Text] [Related]
10. Potential role of the inactivated X chromosome in ovarian epithelial tumor development.
Cheng PC; Gosewehr JA; Kim TM; Velicescu M; Wan M; Zheng J; Felix JC; Cofer KF; Luo P; Biela BH; Godorov G; Dubeau L
J Natl Cancer Inst; 1996 Apr; 88(8):510-8. PubMed ID: 8606379
[TBL] [Abstract][Full Text] [Related]
11. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.
Matsuo K; Tang SH; Fagin JA
Mol Endocrinol; 1991 Dec; 5(12):1873-9. PubMed ID: 1791835
[TBL] [Abstract][Full Text] [Related]
12. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer.
Yang-Feng TL; Li S; Han H; Schwartz PE
Int J Cancer; 1992 Oct; 52(4):575-80. PubMed ID: 1399139
[TBL] [Abstract][Full Text] [Related]
14. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
[TBL] [Abstract][Full Text] [Related]
15. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.
Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K
Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
[TBL] [Abstract][Full Text] [Related]
18. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.
Godwin AK; Vanderveer L; Schultz DC; Lynch HT; Altomare DA; Buetow KH; Daly M; Getts LA; Masny A; Rosenblum N
Am J Hum Genet; 1994 Oct; 55(4):666-77. PubMed ID: 7942844
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss in ovarian cancer.
Yang-Feng TL; Han H; Chen KC; Li SB; Claus EB; Carcangiu ML; Chambers SK; Chambers JT; Schwartz PE
Int J Cancer; 1993 Jun; 54(4):546-51. PubMed ID: 8099899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
